Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
MS NOW, CNN and Politico to sue over White House ban
Afghanistan says Pakistani airstrikes kill at least three
New air traffic control failure delays flights at UK airports
Textile factory fire in southern Chinese city of Foshan kills 8
Typhoon approaches eastern Japan, prompts flood and landslide warnings
